Back to home » Treatment News
 April 24, 2007
|
First CCR5 Blocker Gets Vote of Approval
An advisory committee to the FDA has voted unanimously to recommend the approval of Pfizer’s Celsentri® (maraviroc), an HIV entry inhibitor (EI) that targets the CCR5 receptor on CD4 cells.
|
|
|
April 19, 2007
|
Natural Molecule in Blood Blocks HIV
A new paper published in the journal Cell indicates that researchers have isolated yet another natural ingredient in human blood that effectively blocks the binding of HIV to CD4 cells.
|
|
|
April 13, 2007
|
571 on ADAP Waiting Lists
As of March 2007, four states have reported waiting lists for their ADAPs totaling 571 HIV-positive people in need, according to the 2007 National ADAP Monitoring Project Report.
|
|
|
April 10, 2007
|
Home HIV Test in the Works
OraSure Technologies is looking to petition the U.S. Food and Drug Administration (FDA) to approve the assay for over-the-counter availability and home testing.
|
|
|
Rabies: An HIV Therapy?
New research suggests that the virus responsible for rabies may play a significant role in the development of a vaccine to help treat HIV.
|
|
|
April 06, 2007
|
48-Week Prezista Data Published
The Lancet has published final data from two key clinical trials of Prezista? (darunavir), Tibotec’s new protease inhibitor, indicating that the drug offers prolonged treatment effects for HIV-positive people with limited treatment options.
|
|
|
April 05, 2007
|
Large Study Links Meth Use and HIV Risk
New study results have established methamphetamine use as an independent risk factor for HIV transmission and, when combined with other risk factors like unprotected receptive anal intercourse with multiple partners, the chances of seroconversion increases substantially.
|
|
|
April 02, 2007
|
GSK Reports Combivir and Ziagen Tampering
Third-party tampering has resulted in misbranding of Ziagen® tablets as Combivir® tablets and employed counterfeit labels for Combivir tablets. GlaxoSmithKline is recommended that all Combivir and Ziagen users check their meds.
|
|
|
|
|
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com. |
|
  August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
|
